A contribution by the first of two groups invited to present opposing views on biochemical methods of assessing skeletal muscle breakdown 3-Methylhistidine as a measure of skeletal muscle protein breakdown in human subjects: the case for its continued use
3-Methylhistidine as a measure of skeletal muscle protein breakdown in human subjects: the case for its continued use Fifteen years ago 3-methylhistidine (3-MeH, NTmethylhistidine) was identified as a constituent of both actin [ l ] and myosin [2] . Young, Munro and their coworkers recognized the potential importance of these findings and suggested that the production rate of 3-MeH could potentially be used as an index of muscle protein breakdown [34] provided that:
(a) the 3-MeH was present exclusively in muscle protein and at a constant amount, (b) 3-MeH released after protein degradation was neither re-utilized for protein synthesis nor metabolized, and (c) free 3-MeH was rapidly and quantitatively excreted in the urine.
Initial experiments apparently confirmed all three conditions. Thus 3-MeH has not been found in any proteins other than actin and the myosin heavy chain from white fibres. In both proteins it is present at a constant proportion of 1 mol/mol of protein subunit [S] . Also some 90% of the total body pool of 3-MeH is in skeletal muscle (see below). Administration of radioactive 3-MeH to humans showed that the amino acid was not metabolized but was rapidly excreted in the urine [4] . Previous experiments had confirmed that 3-MeH was not a substrate for amino-acyl tRNA charging in vifro [3] and accordingly could not be reutilized for protein synthesis.
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Thus the total rate of muscle protein breakdown in grams of muscle protein per day per kg body weight is readily obtained as: pmol of 3-MeH day-' kg-' pmol of 3-MeH/g of muscle protein
Furthermore, since the total body pool of skeletal muscle can be estimated from the excretion rate of creatinine, the fractional turnover of muscle protein can be calculated from the excretion ratio of 3-MeH to creatinine. Thus the percentage of muscle protein degraded each day pmol of 3-MeH/ml of urine pmol of creatinine/ml of urine = 100 x 1000 3.63 x 4 x 1 13 X In this expression 3.63 is the pmol of 3-MeH/g of human muscle protein, 4 is based on the assumption that 1 g of creatinine is produced per 4 kg of muscle protein and excreted each day and 113 is the molecular weight of creatinine [6] . It is also evident from this second equation that total daily excretion rates of 3-MeH and creatinine should not be required in order to calculate the fractional turnover rate of muscle protein; rather a molar excretion ratio in a single urine voiding should be adequate. This point has been established by showing that for normal subjects, as well as for a variety of chronic disease states, the excretion ratio in sequential urine samples remains remarkably constant over at least 48 h [6, 7] .
Need for a simple measure of muscle protein metabolism for research purposes and in clinical practice A number of measurements are available which provide some information on whole-body protein metabolism or muscle protein metabolism. Some, including serum protein concentrations or activities of musclederived enzymes such as creatine kinase, are very indirect and difficult to relate in any quantitative way to tissue protein metabolism. Others, for example nitrogen balances or urea excretion rates, are also indirect and require detailed dietary information as well as total urine collections. They give no data specific t o muscle. Nevertheless this latter group of measurements has provided evidence that protein metabolism changes markedly in response to burns, acute infections or other traumatic conditions [8] . A relatively specific measure of muscle protein breakdown would be useful in such states for monitoring the progress of patients and for the evaluation of various therapies. A measurement would be even more attractive if it is non-invasive, can be performed with standard equipment in a normal hospital laboratory and shows relatively rapid changes in response to the changing clinical status of the patient. We argue below that the 3-MeH technique fulfils these conditions.
The requirements for research purposes are less stringent as far as simplicity is concerned, but cannot compromise precision. Whole-body protein synthesis has been measured by radioactive or stable isotopes. However, interpretation of the results requires assumptions with respect to the equilibration of isotopes in either a precursor or a product pool, assumptions which are incorrect in certain cases [9] and can only be accepted with considerable caution under other circumstances. Further, measurement of muscle protein synthesis is not possible without at least one tissue biopsy. The ethical problems associated with this approach, as well as the use of radioactive isotopes, limit the application of such techniques in human research. Longitudinal investigations are excluded except in the most unusual situations. The replacement of radioactive isotopes by stable isotopes alleviates part of the ethical problem, but does not overcome the requirement for a tissue biopsy, and introduces the need for more specialized equipment.
In any examination of the use of the 3-MeH technique, we must consider what altervative measures of muscle-protein breakdown can be applied to humans. Although loss of isotope from muscle protein prelabelled uniformly with a nonradioactive precursor can theoretically be quantified, reproducible biopsies both after labelling and during the degradation period would be needed. Moreover, such a determination would be subject to underestimation caused by reincorporation of the isotope into muscle protein as well as errors introduced by redistribution of isotope between tissues. Even with experimental animals such results must be treated with extreme caution. An alternative approach is to calculate rates of muscle protein breakdown by difference either from synthesis rates and changes in content, or from amino acid flux and amino acid input [lo] . Both of these latter techniques are indirect; they require many assumptions and are subject to independent I errors in the quantification of synthesis, changes in content, flux and input, discussion of which is beyond the scope of this review.
Advantages and limitations of the 3-MeH technique
3-MeH is usually measured after separation of urinary metabolites on an ion-exchange column of an amino acid analyser, or by high performance liquid chromatography. Recently, however, a direct fluorimetric method has been described which permits up to 15 analyses per hour using the Technicon Auto-Analyser [ll] . Since creatinine in urine is also measured conveniently with this equipment, a relatively straightforward and rapid technique is available for quantifying the fractional rate of muscle protein breakdown both for clinical assessment of patients and for research purposes.
Because 3-MeH is produced by the hydrolysis of ingested muscle protein as well as endogenously in the body, muscle protein must be excluded from the diet for 3 days beforehand and during the urine collection period [ 121. This is an inconvenience for patients with chronic disease and is often not possible in acute conditions. However, the dietary restriction does not apply to infants, who do not normally eat muscle, nor when adult subjects are receiving total parenteral nutrition. Accordingly the technique is applicable to patients who are being treated after severe burns and accidents or after gastrointestinal surgery, or to those unable to take an oral diet. Premature infants are an additional group. In each of these states, rates of muscle protein breakdown might be elevated and a convenient monitor could assist treatment.
In this report we are concentrating on the use of the method to evaluate human muscle protein breakdown. The 3-MeH technique has been applied extensively to rats [5] , where a large pro-portion of the excreted amino acid is present in urine as the N-acetylated derivative [3] . 3-MeH excretion is not a satisfactory index of muscle protein breakdown in pigs [13] , sheep [14] or mice (A. J. Murray, unpublished work), either because of the existence of a large and variable muscle pool of the 3-MeHcontaining dipeptide, balenine; or because 3-MeH is extensively metabolized.
What proportion of the urinary 3-MeH is derived from skeletal muscle in adult human subjects?
We mentioned above that all three criteria originally put forward as conditions for the valid use of the 3-MeH technique had 'apparently' been satisfied. But one question remaining is how much of the excreted 3-MeH is derived from actin or myosin degradation in non-muscle tissues? The extent of the problem is evident after examining the data presented in Table 1 , where tissue weights and contents of 3-MeH are expressed relative to a 70 kg subject. The values are obtained from the 'standard man' [15] , measured contents of 3-MeH/g of protein [16] and the assumption that the wet weight of each tissue is five times the protein content. This assumption is correct for muscle [12] but would overestimate the contribution of 3-MeH if tissues contained lipid. A second assumption, that 'skin' quoted by Elia etal, [16] includes both skin and all the connective tissue outside major organs, may also overestimate the 3-MeH contribution. We have assumed that. the skeleton and adipose tissue contain only trivial amounts of 3-MeH.
The calculations in Table 1 show that skeletal muscle accounts for 91% of the whole-body 3-MeH pool, with additional significant amounts being produced by the gastrointestinal tract (3.1%) and skin plus connective tissues (3.3%). If the contribution from these two minor sources is to account for a substantial portion of the 3-MeH excretion, the respective protein breakdown rates must be very much greater than in skeletal muscle. For example, if in fact muscle accounted for 75% of the excreted 3-MeH, and skin, intestine and connective tissue the residual 25%, the protein breakdown rate in the non-muscle tissues would need to be nearly five times the rate in muscle.
Rennie et QZ. [ 171 cited analyses showing that skin
and gut protein turnover is two and five times the rate of skeletal muscle protein turnover respectively in patients undergoing elective surgery.
A separate estimate of the contribution of nonmuscle sources is provided by measurement on a patient without histologically identifiable skeletal muscle [18] . The 3-MeH excretion rate of this subject was 25% of that of normal controls, a figure similar to the example calculated above. However, 25% would be an overestimate if residual skeletal muscle was present, as seems likely, because the creatinine excretion rate remained at 17% of controls even though non-muscle sources of creatinine are thought to contribute a very minor portion of the urinary excretion rate: e.g. 2% [19] . Nevertheless, on balance it seems reasonable to take 25% as an upper limit to the proportion of urinary 3-MeH being derived from sources other than skeletal muscle in adult human subjects.
Use of the 3-MeH method in adults with a normal body proportion of muscle
The fractional rate of muscle protein breakdown as calculated from the 3-MeH/creatinine excretion ratio is increased about twofold in hyperthyroidism [6, 20, 21] , a similar extent during the acute phase of dermatomyositis [6] and up to fourfold after trauma [6, 22, 23] . In the fiist two states creatinine excretion is normal, so that similar quantitative results are obtained if breakdown is calculated from the 3-MeH excretion rate alone. However, an even greater calculated rate of muscle protein breakdown is obtained from the 3-MeH production rate in trauma patients, because the creatinine excretion rate is usually elevated and accordingly overestimates the muscle mass [6, 22] . We consider that the use of the 3-MeH/creatinine ratio in urine samples or, if clinically feasible, the 24 h 3-MeH production rate provides a useful index of the severity of muscle protein breakdown in hyperthyroidism, dermatomyositis and after trauma. Several studies show a.correlation between clinical improvement of these conditions and the return of the calculated muscle protein breakdown rate to normal [6, . The 3-MeH/creatinine excretion ratio is depressed to about half during prolonged exercise [25] or in hypothyroid conditions [6, 21] . The ratio returns to normal in the former example once exercise is terminated and in the latter case upon successful treatment with thyroid hormone.
In most of the examples cited above for increased or depressed 3-MeH/creatinine ratios, comparable studies have been performed with experimental animals. Not only are the changes qualitatively similar to those observed in humans, but they have frequently been corroborated by independent measurements of muscle protein catabolism [5, . Furthermore, if by some chance a twofold increase in the overall 3-MeH excretion rate found in the human conditions reflected changes in skin, connective tissue or gut, but not in muscle, the observed production rate would require an eightfold increase in protein breakdown in those tissues if they were contributing 25% of the total 3-MeH under normal conditions. This seems most unlikely because a twofold increase in protein breakdown is difficult to achieve even in isolated tissues or cells where heroic concentrations of hormones and nutrients can be tested [30, 31] . Moreover, it is impossible to account for the 50% fall in the 3-MeH production rate seen during exercise or in hypothyroidism without invoking a fall in muscle protein breakdown if non-muscle sources of 3-MeH contribute only 25% of the basal excretion rate.
Use of the 3-MeH method in subjects with low muscle content A problem of interpretation arises in subjects where the proportion of muscle in the body is markedly diminished. For example, if the actual production rates of 3-MeH per unit of protein was not altered in any tissue, and if the initial contribution of skeletal muscle to urinary 3-MeH was 75% of the total, then a reduction of the muscle mass to one-third with the substituted tissue not containing 3-MeH would reduce the proportion of muscle-derived 3-MeH t o 50%. This figure would be even lower if, as seems likely, skin, gut or connective tissue contribute a greater proportion to the body weight than in normal subjects.
Two situations where the 3-MeH method has been applied and which may fit the above pattern are premature infants and Duchenne muscular dystrophy. Estimates of muscle mass calculated from creatinine excretion rates in 1000 g premature infants indicated that an average of only 11% of the body weight was muscle [32] . Since the 3-MeH excretion rate per kg of body weight in these infants was similar to that of adult subjects, provided allowance is made for the somewhat lower 3-MeH content of infant muscle, the rate of muscle-protein breakdown rate calculated from the 3-MeH/creatinine ratio was about fourfold higher in the infants. Does this represent a true assessment? Two indirect approaches support the validity of the observation. First, whole-body protein breakdown rates of 15.5 g day-lkg-lhave been reported for premature infants, compared with 3.0 g day-' kg-' in young adults [33, 34] , a difference that is even greater than calculated for muscle protein breakdown. Second, rates of muscle-protein synthesis and catabolism in animals, calculated from isotope infusion experiments, show a similar large fall with age [35-371. The situation in Duchenne dystrophy is more controversial. The 3-MeH/creatinine ratio is increased between two-and four-fold, but entirely as a consequence of a very low rate of creatinine excretion [ 17, 20, 38, 39] . However, this low rate and the resultant calculated myofibrillar mass is in general agreement with clinical evaluation, provided allowance is made for infiltration of nonmuscular tissue between myofibrils. Contrary evidence has been reported by Rennie el al. [17] , who showed that muscle protein synthesis measured after infusion of [13C]leucine was only onethird that in adults. Breakdown would be similarly reduced as the muscle protein content of these boys is reasonably constant. Age-matched controls were not used, a consequence of the need for muscle biopsies. But we must assume from the argument outlined in the previous paragraph that unaffected children have an even higher rate of muscle protein turnover than adults, making the discrepancy even worse between conclusions drawn from the infusion method and the 3-MeH/ creatinine excretion ratio. Perhaps the infusion method used with the dystrophic boys has some unforeseen technical problem, such as inappropriate use of a-ketoisocaproate enrichment for estimating the enrichment of the leucine pool, or inadequate sampling of true muscle by the needle biopsy. Certainly the conclusion that protein breakdown is markedly depressed in dystrophic muscle is contrary to increases with various animal dystrophies observed in vivo or in perfused muscle and indicated by the high activities of muscle proteinases [40-451. Resolution of this difference must be given a high research priority.
The 3-MeH technique has been applied to dystrophic patients undergoing drug trials. In general no changes in excretion ratio have been found (for example see [46] ) but recently Stewart et al.
[47] demonstrated a significant fall in the ratio in Duchenne patients fed with branched-chain keto acids. Since creatinine output was not affected, the reduced ratio was clearly a consequence of decreased actin plus myosin catabolism.
Does production of 3-MeH measure muscle protein breakdown, myofibrillar protein breakdown or actin breakdown?
It can be calculated that in adults about 80% of the excreted 3-MeH is derived from actin and 20% from myosin. In newborn infants who have no 3-MeH in the myosin heavy chain of white fibres, the proportion derived from actin would approach 100% [S]. Thus there is no doubt that 3-MeH excretion provides a measure of actin breakdown. Is this representative of total muscle protein breakdown? Most investigations in animals have shown that degradation rates for total muscle protein are slightly higher than those for myofibrillar protein and that actin turnover is usually but not always less than myosin turnover [48-5 11. In humans the rate of sarcoplasmic protein breakdown is also higher than myofibrillar protein breakdown [52] , so that extrapolation from 3-MeH excretion rates would underestimate true rates of muscle protein turnover.
Actin plus myosin comprise 65% of the protein in muscle and usually 30-35% of the total body protein pool [5] . They are the two most abundant proteins in the body, so that any accurate and simple measurement of their average breakdown rate should be valuable, Certainly it is important whether the 3-MeH is derived 100% or 85% or 75% from muscle, or perhaps even less in wasting conditions, but the search for the correct proportion should be carried out in parallel and should not inhibit use of the routine method. It would be gratifying to know that the fall in 3-MeH production observed (for example when a patient is receiving a new treatment after severe trauma) truly represents a fall in muscle protein breakdown; but the really important point is that protein breakdown has been reduced by the intervention. Indeed it may be more significant if the fall is not confined to muscle but rather reflects a generalized change in several tissues. The method could then be used as an index of whole-body protein metabolism.
We would like to reiterate that 3-MeH excretion provides us with a non-invasive method for measuring protein degradation in vivo which can be readily applied to longitudinal patient studies, with the only proviso being that a muscle-free diet is needed. It requires only urine samples without the complexity of constant patient attention, it does not need expensive equipment or an expert research unit and it is based on only two measurements, of creatinine and 3-MeH, both of which can now be performed rapidly and precisely with fully automated equipment. Although we cannot define exactly the proportional contribution from the various tissues, 3-MeH excretion surely is an index. of the breakdown rate of some one-third of the total body protein. With care this index can be employed to assess the status of protein metabolism in human subjects.
